April 29, 2019
1 min watch
Save

VIDEO: AI-based diabetic retinopathy screening device shows ‘exceptional results’

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

VANCOUVER, British Columbia — Kaushal Solanki, PhD, founder and CEO of Eyenuk Inc., discusses study results of the EyeArt AI Screening System for autonomous detection of diabetic retinopathy at the Association for Research in Vision and Ophthalmology meeting.

The prospective, multicenter, pivotal clinical trial found “exceptional results,” according to Solanki.